Journal article
Bisphosphonate Associated Osteonecrosis of the Jaw
Abstract
In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphonate therapy. We present the results of a systematic review of the incidence, risk factors, diagnosis, prevention, and treatment of BP associated ONJ. …
Authors
Khan AA; Sándor GKB; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Lentle B
Journal
The Journal of Rheumatology, Vol. 36, No. 3, pp. 478–490
Publisher
The Journal of Rheumatology
Publication Date
March 2009
DOI
10.3899/jrheum.080759
ISSN
0315-162X